These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 14701785)

  • 21. [Treatment of intestinal and urinary tract obstruction in patients with advanced ovarian disease].
    Imparato E; Parodi M
    Minerva Ginecol; 2001 Feb; 53(1 Suppl 1):46-7. PubMed ID: 11526719
    [No Abstract]   [Full Text] [Related]  

  • 22. [Search for an operability score in patients with ovarian cancer in intestinal occlusion].
    Scarabelli C; Sopracordevole F; Campagnutta E; Miotto E; Tumolo S; Grigoletto E
    Minerva Ginecol; 1988 Sep; 40(9):517-30. PubMed ID: 3222007
    [No Abstract]   [Full Text] [Related]  

  • 23. Intestinal obstruction in patients with ovarian cancer. Variables associated with surgical complications and survival.
    Clarke-Pearson DL; DeLong ER; Chin N; Rice R; Creasman WT
    Arch Surg; 1988 Jan; 123(1):42-5. PubMed ID: 3337655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The management of recurrent ovarian cancer.
    Bukowski RM; Ozols RF; Markman M
    Semin Oncol; 2007 Apr; 34(2 Suppl 2):S1-15. PubMed ID: 17512352
    [No Abstract]   [Full Text] [Related]  

  • 25. [Benefit of palliative surgery for bowel obstruction in recurrent ovarian carcinoma].
    Li ZT; Wu XH; Fu SL
    Zhonghua Fu Chan Ke Za Zhi; 2004 Apr; 39(4):260-3. PubMed ID: 15130355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Remote results of the standard ovary cancer treatment].
    Ushakov II; Mel'ko AI; Kira EF; Ermolinskiĭ II
    Voen Med Zh; 2005 Nov; 326(11):36-8. PubMed ID: 16404905
    [No Abstract]   [Full Text] [Related]  

  • 27. [Malnutrition in cancer patient: when to have a specialized consultation?].
    Antoun S; Baracos V
    Bull Cancer; 2009 May; 96(5):615-23. PubMed ID: 19423487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Relationship between CA125 half life during neoadjuvant chemotherapy and the optimal operation rate and prognosis in patients with advanced epithelial ovarian carcinoma].
    Xi XW; Wan XP; Li SD; Sun TW; Zhu YP
    Zhonghua Fu Chan Ke Za Zhi; 2006 Feb; 41(2):91-4. PubMed ID: 16640855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic radiation enteritis after ovarian cancer: from home parenteral nutrition to oral diet.
    Vidal A; de la Cuerda C; Luis Escat J; Bretón I; Camblor M; García-Peris P
    Clin Nutr; 2006 Aug; 25(4):701-4. PubMed ID: 16759759
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Symptom scores, serotonin and 5-hydroxyindole acetic acid levels in cancer patients with and without bowel obstruction.
    Bennett MI; Livingstone HJ; Costello P; Allen KR; Degg TJ
    Palliat Med; 2007 Mar; 21(2):157-9. PubMed ID: 17344265
    [No Abstract]   [Full Text] [Related]  

  • 31. [Pharmacotherapy in ovarian carcinoma].
    Pfisterer J; Du Bois A
    MMW Fortschr Med; 2005 Oct; 147(43):34-6. PubMed ID: 16302419
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Considerations on a case of intestinal occlusion caused by a voluminous carcinoma puellarum (torsion on the pedicle)].
    Cappelli G
    Minerva Ginecol; 1966 Feb; 18(4):185-6. PubMed ID: 5934713
    [No Abstract]   [Full Text] [Related]  

  • 33. Quality of life in ovarian cancer patients: comparison of paclitaxel plus cisplatin, with cyclophosphamide plus cisplatin in a randomized study.
    Bezjak A; Tu D; Bacon M; Osoba D; Zee B; Stuart G; Roy JA; Piccart M; Eisenhauer E
    J Clin Oncol; 2004 Nov; 22(22):4595-603. PubMed ID: 15466785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ovarian cancer.
    Oates-Whitehead R
    Clin Evid; 2004 Jun; (11):2493-506. PubMed ID: 15652119
    [No Abstract]   [Full Text] [Related]  

  • 35. The prognostic effects of performance status and quality of life scores on progression-free survival and overall survival in advanced ovarian cancer.
    Carey MS; Bacon M; Tu D; Butler L; Bezjak A; Stuart GC
    Gynecol Oncol; 2008 Jan; 108(1):100-5. PubMed ID: 17920108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Evaluating treatment from the point of view of the patient -PROs (patient-reported outcomes)].
    Bördlein-Wahl I; Hilpert F; Kohlmann T
    Onkologie; 2009; 32 Suppl 1():18-20. PubMed ID: 19521131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Controlled study of fatigue, quality of life, and somatic and mental morbidity in epithelial ovarian cancer survivors: how lucky are the lucky ones?
    Liavaag AH; Dørum A; Fosså SD; Tropé C; Dahl AA
    J Clin Oncol; 2007 May; 25(15):2049-56. PubMed ID: 17513809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclophosphamide "metronomic" chemotherapy for palliative treatment of a young patient with advanced epithelial ovarian cancer.
    Samaritani R; Corrado G; Vizza E; Sbiroli C
    BMC Cancer; 2007 Apr; 7():65. PubMed ID: 17433113
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Malignant ovarian cancer: conservative treatment and quality of life in young patients].
    Ivanov S
    Akush Ginekol (Sofiia); 2008; 47(5):11-3. PubMed ID: 19227771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The predictive and prognostic value of serum CA 125 half-life during paclitaxel/platinum-based chemotherapy in patients with advanced ovarian carcinoma.
    Gadducci A; Cosio S; Fanucchi A; Negri S; Cristofani R; Genazzani AR
    Gynecol Oncol; 2004 Apr; 93(1):131-6. PubMed ID: 15047226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.